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INTRODUCTION 
 
The Hayflick limit of primary mouse embryo fibroblasts 
(MEF) is variable since the growth conditions can either 
reduce or extend it [1-3]. We have reported that primary 
MEF  expanded  every  three  days  (6T3  protocol) 
underwent four population cell doubling and thereafter 
cell  proliferation  was  fully  abolished  and  SA-β-gal
+ 
cells  induced  [4].  However  it  is  known  that  MEF 
senescence can be induced prematurely, before the end 
of the physiological lifespan, by cellular stresses such as 
the over expression [5] or down regulation [6] of single 
oncogenes and DNA damaging drugs [7-9]. Recently, it 
has  been  reported  that  miRNAs  are  involved  in 
senescence  of  MEF  as  well  as  of  human  diploid 
fibroblasts [10, 11].  
 
An  unsolved  question  is  which  cells  are  able  to     
escape the in vitro lifespan limit. So far, the molecular 
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characterization  of  immortalized  MEF  cell  lines  has 
shown  that  functional  silencing  of  either  the 
INK4a/ARF locus [12] or p53 [13] appears necessary to 
bypass  senescence.  A  recurrent  concept  is  that 
mutational events occurring in culture have a key role. 
If mutations confer a proliferative advantage, mutated 
cells can bypass the in vitro lifespan limit and rapidly 
replace the existing population [14, 15]. According to 
this  view,  the  time  spent  in  culture  should  affect 
immortalization.  We  modified  the  6T3  expansion 
protocol of primary MEF [4] by lengthening the interval 
between  passages  (15  days  versus  3  days)  and 
reiterating  it  until  MEF  became  immortal.  Here  we 
report  that:  i)  the  life  span  was  extended  up  to  8 
population  cell  doubling  and  immortalization  was 
consequentially delayed; ii) p21 down regulation marks 
the  switch  from  primary  to  immortalized  MEF;           
iii) deregulation of genes and miRNAs which control 
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immortalization  process;  iv)  down  regulated  miRNAs 
can behave as tumor suppressors. 
 
RESULTS 
 
1. The pro senescence axis p53/p21 is disrupted in 
immortalized MEF. 
 
To  investigate  the  relative  importance  of  the  time  in 
culture versus the number of population cell doubling in 
the MEF immortalization process we modified the split 
time. MEF p0 (passage 0) were thawed, and expanded 
to obtain MEF p1. Thereafter MEF p1 were collected, 
diluted  at  the  appropriate  concentration  (6x10
5)  and 
grown for 15 days with a medium change every three 
days (6T15 protocol), before the next trypsinization and 
expansion. The 6T15 protocol was reiterated 10 times 
for a total of 150 days in culture. During the first three 
passages a reduced number of population cell doubling 
was observed; afterwards a population of proliferating 
MEF  emerged,  which  rapidly  increased  (p5)  and 
replaced the preexisting cell population (p10) (Fig. 1A). 
At the molecular level we found that both p19ARF and 
p16  were  progressively  up  regulated  during  passages 
(with respect to the spontaneous level of MEF p0) (Fig. 
1B).  Vice  versa  the  expression  of  p21  was  biphasic: 
while it was up regulated till p3 it decreased thereafter 
with a clear switch toward under expression at p6 (Fig. 
1B,C).  As  p21  is  under  the  direct  control  of  p53,  a 
disruption of the p53/p21 axis can be hypothesized at 
the basis of immortalization. 
 
2.  Genome  stability  and  miRNA  signatures  are 
modified in immortalized MEF. 
 
The down regulation of p21 strongly suggests a loss of 
p53 activity. In accordance with the hypothesis, FACS 
analysis  showed  that  while  the  DNA  content 
distribution curve per cell of MEF p1 and MEF p5 were 
very  similar  and  typical  of  diploid  cells  (Fig.  2A)  a 
massive  shift  toward  cells  with  higher  DNA  contents 
was observed in MEF p6 (Fig. 2B). Hyperdiploid cells, 
which  emerged  from  diploid  primary  MEF,  are 
indicative that genomic stability, controlled by p53 [16-
18], is lost. It is of note that a stable hyperdiploid cell 
population  is  selected  within  four  passages  (p6-p10) 
(Fig. 2C). To strengthen the hypothesis of a functional 
loss of p53, in parallel we determined the expression 
profiles of p53 and of miR-34a directly controlled by 
p53. We found that p53 mRNA (Fig. 2D) and protein 
levels did not significantly change up to p6 (Fig. 2E); 
conversely miR-34a appears to increase till p4, starts to 
decrease at p5 to become markedly down regulated at 
p6 (Fig. 2D) reinforcing the idea that p53 becomes non-
functional. 
 
 
 
 
 
 
 
 
 
 
3.  The  senescence  related  miRNAs  are  down 
regulated in immortalized MEF. 
 
As the p53/p21 axis of primary MEF was disrupted in 
immortalized  MEF,  we  investigated  whether  the  time 
course  of  the  signatures  of  miRNAs  related  to  either 
premature (miR-20a [19]) or replicative (miR-21, miR-
28 [20], miR-290 [4]) primary MEF senescence were 
also modified. The analysis showed that while miR-20a 
and miR-290 were down regulated till p6 (Fig 3A) miR-
21 and miR-28 were up regulated. It is worth noting that 
the up regulation of miR-21 and miR-28 is in agreement 
with  findings  in  MEF  replicative  senescence,  while 
miR-290  down  regulation  is  the  opposite  of  previous 
observations  because  we  have  shown  that  miR-290 
steadily  increased  when  either  spontaneous  or 
nocodazole-induced  MEF  G1  blocked  tetraploid  cells 
were present [4]. For that, we examined the cell cycle of 
p1-p5  MEF.  We  found  that  under  6T15  protocol  no 
significant  accumulation  of  G2/M  cells  was  observed 
(Fig.  3B)  suggesting  that  the  failed  accumulation  of 
G2/M cells was responsible for the lack of miR-290 up 
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Figure  1.  Characterization  of  MEF  under  6T15  propagation 
regimen.  (A)  Proliferation  curve  of  MEF  expressed  as  cell 
doublings  per  passage.  (B)  Quantification  of  p19ARF,  p16  and 
p21 transcripts per passage (each point represent one passage) 
normalized to that of MEF at passage 0. (C) p21 protein level at 
the  various  passages.  The  value  reported  under  each  lane 
represents the average of two independent experiments. regulation.  The  miRNA  signatures  changed  markedly 
after  p6:  while  miR-20a  and  miR-290  remain  down 
regulated, although to a lesser extent, miR-21 and miR-
28  switched  from  up  to  down  regulation  (Fig.  3A). 
These data suggest that the deregulation of these two 
senescence  related  miRNAs,  besides  miR-34a,  is 
involved in MEF immortalization. 
 
 
 
 
 
 
 
 
 
 
4. The transfection of the down regulated miRNAs 
reduces the proliferation of immortalized MEF. 
 
To investigate if the deregulated miRNAs play an active 
role  in  the  immortalization,  immortalized  MEF  (p10) 
were transfected with miR-21, miR-28 and miR-34. In 
addition  we  tested  miR-20a  and  miR-290  whose 
expression was not affected by the immortalization. The 
proliferation  data  showed  that  miR-20a  and  miR-290 
did not affect cell proliferation as expected, the down 
regulated miR-28 and miR-34 significantly reduced the 
proliferation  of  immortalized  MEF  with  similar 
efficiency,  while  miR-21  did  not  inhibit  cell 
proliferation (Fig. 3C). These data indicate that the re-
expression of miR-34a and miR-28 (and consequently 
of their controlled pathways) was sufficient to reduce 
the proliferative rate of immortalized MEF and suggest 
that miR-28, like the tumor suppressor miR-34a, could 
have a tumor suppressor activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. MiR-28 behaves as tumor suppressor miRNA. 
 
It is well known that miR-34a has a widespread tumor 
suppressor activity [21, 22]. We show that it behaved as 
such in immortalized MEF as its re-expression inhibits 
cell proliferation, probably by partially restoring the p53 
pathway. Interestingly miR-28, as far as we know, is not 
directly linked to the p53 controlled pathways. We have 
previously reported that in primary MEF miR-28 targets 
the proto-oncogenic splicing factor ASF/SF2 and that in 
turn miR-28 over-expression induces both apoptosis and 
senescence  of  primary  MEF  via  ASF/SF2  down 
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Figure  2.  MEF  immortalization  is  characterized  by  a  p53-
dependent events.  DNA content profile per cell at p1/p5 (A), 
p5/p6 (B) and p6/p10 (C). (D) Fold change of miR-34a and p53 
transcripts  at  various  passages  normalized  to  that  of  MEF  at 
passage  0.  (E)  p53  protein  level  at  the  various  passages.  The 
value reported under each lane represents the average of two 
independent experiments. 
 
Figure  3.  The  re-expression  of  miRNAs  down  regulated  in 
immortalized MEF reduces cell proliferation. (A) Quantification 
of miR-20a, miR-21, miR-28, miR-290 and miR-34a per passage 
normalized to that of MEF at passage 0. Dashed lines indicate 
the  transition  from  passage  5  to  6.  (B)  Cell  cycle  phase 
distribution  (%)  of  MEF  from  p1  to  p5.  (C)  Population  cell 
doubling of immortalized MEF after transfection of miR-NC, miR-
20a, miR-21, miR-28, miR-290 and miR-34a. Each bar represents 
the  mean  ±  SD  of  three  biological  replicates  (*=p<0.05).  (D) 
Expression  of  ASF/SF2  protein  in  primary  (p3  and  p5)  and 
immortalized  (p10)  MEF.  The  value  reported  under  each  lane 
represents  the  average  of  two  independent  experiments.  (E) 
Expression  of  ASF/SF2  after  the  transfection  of  immortalized 
MEF with either miR-NC or miR-28 . The value reported under 
each  lane  represents  the  average  of  two  independent 
experiments. 
 regulation  [20].  This  prompted  us  to  verify  the 
expression  of  ASF/SF2  in  primary  and  immortalized 
MEF.  As  expected  the  expression  of  ASF/SF2  was 
higher in immortalized than in primary MEF (Fig. 3D) 
suggesting  a  possible  post  transcriptional  control  of 
miR-28  on  ASF/SF2  expression.  To  confirm  the 
hypothesis,  we  transfected  immortalized  MEF  (p10) 
with  miR-28  and  found  50%  reduction  of  ASF/SF2 
expression  (Fig.  3E),  suggesting  that  miR-28  control 
cell proliferation by targeting ASF/SF2. These  results 
strengthen the idea that miR-28 has a tumor suppressor-
like activity and might be suitable to be tested in tumor 
cell lines defective in miR-28 content. 
 
DISCUSSION 
 
The in vitro life span defines the number of population 
cell  doubling  which  primary  cells  can  undergo  in 
culture.  We  have  reported  that  MEF  under  the  6T3 
expansion  regimen  were  able  to  undergo  four 
population cell doubling before achieving senescence . 
In  this  work  we  reported  that  by  modifying  the 
propagation  regimen  and  growth  conditions  (6T15 
protocol)  MEF  slowed  down  without  reaching  a 
complete  cell  proliferation  block  and  restarted 
proliferation after about eight population cell doubling 
(passage 3). These results suggest that activation of p53 
with the consequent induction of p21 in this case may 
favor  proliferation  arrest  rather  than  senescence  as 
previously described [23]. Interestingly the in vitro life 
span of MEF was extended both in terms of  population 
cell doubling and in terms of days in culture, in keeping 
with  the  hypothesis  that  p53  activation,  by  inducing 
quiescence rather than senescence may increase the cell 
life span [24]. The immortalization process is delayed 
accordingly, suggesting that it does not strictly depend 
on the number of cell doubling or the time that the cells 
spend in culture (45 culture days in this case).  
 
The spontaneous immortalization of primary MEF has 
been attributed to either the inactivation of p53 or the 
loss of the INK4a/ARF locus (p19ARF, p16) [25], two 
loci strictly related to cell proliferation. In this work we 
found  that  both  loci  were  transcribed  and  translated 
during passages whereas p21 shifted from up to down 
regulation  after  p5.  As  p21  expression  is  mostly  p53 
dependent we argued that despite p53 continued to be 
expressed, it may not be functional any more. In support 
of this conclusion are the down regulation of the p53 
dependent  miR-34a  and  the  loss  of  genomic  stability 
revealed  by  the  massive  appearance  of  hyperdiploid 
cells [16-18] 
 
A  recurrent  concept  is  that  immortalization  is  due  to 
mutations  induced  by  DNA  damage  occurring  during 
the population expansion [14]. The loss of p53 activity 
found in immortalized MEF could be due to either point 
mutation  or  loss  of  one  allele  which  appears  to  be 
sufficient to alter cell growth [15]. In any case the sharp 
increase  of  cell  proliferation  suggests  that  the 
immortalization process is  caused by the concomitant 
alteration  of  multiple  pathways.  We  found  that  the 
expression of miR-20a, miR-21, miR-28 and miR-290, 
all  involved  in  MEF  senescence,  were  deregulated  in 
coincidence with p21 down regulation and increase of 
cell  proliferation.  As  a  high  number  of  genes  are 
potentially targeted by one miRNA [26], we argued that 
the  deregulation  of  these  miRNAs  could  be  in  part 
responsible for the absence of cell proliferation control 
characteristic  of  immortal  cells.  In  particular  we 
demonstrate  that  by  replacing  miR-28  and  miR-34a, 
under expressed in immortalized MEF, cell proliferation 
was  reduced  suggesting  that  both  miRNAs  are 
implicated in immortalization. Evidence in support of 
an anti proliferative role of miR-28 is already available. 
We have shown in primary MEF that miR-28 targets the 
proto-oncogene ASF/SF2, a splicing factor involved in 
the alternative splicing of many transcripts [27, 28] and 
its over expression induces apoptosis and senescence by 
down regulating ASF/SF2 [20]. Our results demonstrate 
that also in immortalized MEF miR-28 targets ASF/SF2 
suggesting that its tumor suppressor activity is due to 
ASF/SF2  inhibition,  although  other  targets  cannot  be 
excluded. 
 
The  fact  that  the  replacement  of  miR-28  in 
immortalized  MEF  reduced  cell  proliferation  to  the 
same  extent  as  miR-34a  further  strengthens  the 
hypothesis that miR-28 represents a novel TS miRNA. 
MiR-34a is a well known TS miRNA able to inhibit cell 
proliferation of a wide range of tumor cells [21, 29-31] 
as  well  as  of  human  fibroblasts  which  extend  their 
replicative  capacity  when  treated  with  miR-34a 
antisense  [32].  Conversely  miR-290  and  miR-20a 
involved  in  culture  and  stress  induced  senescence  of 
primary MEF were not able to inhibit proliferation of 
immortal MEF in keeping with the idea that miRNAs 
behave differently in different cellular context [33]. In 
conclusion  the  delayed  immortalization  obtained  with 
this protocol implies that point mutations; due to DNA 
damage accumulated during population expansion [14], 
are  not  the  only  molecular  events  at  the  basis  of 
immortalization. The most notable feature which marks 
the  immortalization  process  is  the  drastic  p21  down 
regulation possibly due to p53 functional inactivation. 
Associated to the sudden down regulation of p21 was 
the induction of hyperploidy, suggesting that genomic 
instability  and/or  epigenetic  changes  are  also 
responsible  for  the  immortalization  process. 
Interestingly,  the  switch  of  p21  expression  was 
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related  to  MEF  senescence,  including  the  p53-
dependent miR-34 and miR-28 [20]. In particular, the 
down regulated miR-28, behaved as a TS miRNA, when 
transfected  in  immortalized  MEF,  analogously  to  the 
well known TS miR-34a, indicating that the comparison 
of the miRNA signature of primary versus immortalized 
cells  could  allow  the  identification  of  novel  miRNAs 
with potential tumor suppressor-like activity. 
 
MATERIALS AND METHODS 
 
Reagents.  miRNeasy  mini  kit,  QuantiTect  Reverse 
Trascription  Kit,  miScript  Reverse  Transcription  Kit, 
miScript  SYBR  Green  PCR  Kit  (QIAGEN,  Milano, 
Italy);  Dulbecco’s  Modified  Eagle  Medium-High 
Glucose  (D-MEM-HG),  foetal  bovine  serum  (FBS) 
(Invitrogen, CA, USA); LightCycler 480 Probes Master, 
Universal ProbeLibrary LNA Probes; LightCycler 480 
SYBR Green I Master (Roche Diagnostic, Mannheim, 
Germany);  X-Gal  (5-bromo-4-chloro-3-indolylb-D-
galactoside);  propidium  iodide,  anti-α-tubulin  (Sigma-
Aldrich Corporation, Missouri, USA); anti-p21 (Santa 
Cruz  Biotechnology,  Inc.);  ECL,  Hybond-C  extra 
membranes  (Amersham);  anti-p53  (Cell  Signaling 
Technology).  The  anti-ASF/SF2  was  a  gift  of  Dr. 
Adrian  Krainer.  MiR-20a,  miR-21,  miR-28,  miR-34, 
miR-290 and miR-NC (negative control) (GenePharma 
Shanghai, China) 
 
Cells and culture conditions. MEF were isolated from 
13.5d  mouse  embryos,  expanded  and  then  replated 
every  three  days  (6T3  protocol).  For  6T15  protocol 
MEF  p1  were  collected,  diluted  at  the  appropriate 
concentration  (6x10
5)  and  grown  for  15  days  with  a 
medium  change  every  three  days,  before  the  next 
trypsinization  and  expansion.  MEF  were  grown  in 
Dulbecco’s  Modified  Eagle  Medium-high  glucose 
(DMEM-HG)-10%  FBS  at  37°C  in  a  humidified 
atmosphere containing 6% CO2. 
 
Cell  proliferation.  Cell  proliferation  was  measured  as 
number of population cell doubling per passage (CD= 
ln(Nf/Ni)/ln2) where Nf is the final number of collected 
cells (day 3) and Ni the initial number of seeded cells 
(day 0).  
 
MiRNAs  transfection.  Immortalized  MEF  (p10)  were 
seeded at cell density of 1.0x10
5 per 30 mm diameter 
dish. After 24 hours cells were transfected with either 
miRNAs  under  test  or  a  double-stranded 
oligonucleotide,  named  miR-NC.  Briefly,  15  μl 
Optimem  and  25  μl  transfection  buffer  plus  80  nM 
miRNA were mixed with a solution of Gene Silencer (5 
μl) plus Optimem (25 μl). After 15 minutes incubation, 
Optimem was added up to 800  μl. After 6 hours the 
medium was replaced with complete DMEM. 
 
Quantification of miRNAs and genes with Q-Real-time 
PCR. Total RNA was extracted from 1x10
6 cells using 
the  miRNeasy  mini  kit  (Qiagen)  following  the 
manufacturer’s recommendations. To quantify p19ARF, 
p16 and p21 transcripts, 1µg of total RNA was reverse 
transcribed using QuantiTect Reverse Trascription Kit 
(Qiagen).  Real-time  PCR  (qRT-PCR)  was carried  out 
with  LightCycler  480  (Roche)  using  LightCycler  480 
SYBER  Green  I  Master  (Roche).  Mature  miR-20a, 
miR-21, miR-28, miR-34a and miR-290 were quantified 
using  the  miScript  System:  1µg  of  total  RNA  was 
retrotranscribed  with  miScript  Reverse  Transcription 
Kit  (Qiagen)  and  qRT-PCR  was  carried  out  using 
miScript SYBR Green PCR Kit (Qiagen). All reactions 
were performed in triplicate. Relative quantification of 
gene  expression  was  calculated  with  the  fit  point 
method. Transcript values were normalized with those 
obtained from the amplification of the internal controls 
(GAPDH  for  transcripts  and  U6  for  miRNAs).  The 
following  oligonucleotides  were  used:  p19ARF, 
forward (F) (5'-CATGGGTCGCAGGTTCTTG-3’) and 
reverse (R) (5'-GCTCGCTGTCCTGG GTCTC-3'); p16, 
F  (5'-CGACGGGCATAGCTTCAG-3')  and  R  (5'-
GCTCTGCTCTTGGGATTGG-3');  p21,  F  (5'-
TCCACAGCGATATCCAGACA-3')  and  R  (5'-
GGACATCACCAGGATTGGAC-3');  p53,  F  (5'-
ATGCCCATGCTACAGAGGAG-3')  and  R  (5'-
AGACTGGCCCTTCTTGGTCT-3');  GAPDH,  F  (5'-
GCCTTCCGTGTTCCTACCC-3'),  R  (5'-
TGCCTGCTTCACCACCTTC-3');  miR-20a,  F  (5'-
TAAAGTGCTTATAGTGCAGGTAG-3');  miR-21,  F 
(5'-TAGCTTATCAGACTGATGTTGA-3'),  miR-28,  F 
(5'-AAGGAGCTCACAGTCTATTGAG-3');  miR-34a, 
F  (5'-TGGCAGTGT  CTTAGCTGGTTGT-3');  miR-
290,  F  (5'-gctaatcttctctgtatcgttccaa-3');  U6,  F  (5'-
CGCAAGGATGACACGCAAATTC-3'). 
 
Western Blot analysis. Equivalent amounts of proteins 
were resolved on 10% SDS-PAGE gels and transferred 
to Hybond-C extra membranes by electro blotting. The 
resulting blots were blocked with 5% nonfat dry milk 
solution. Anti-α-tubulin (1:1000), anti-p53 (1:500), anti-
p21  (1:1000),  anti-ASF/SF2  (1:2000)  were  used. 
Incubation was performed overnight at 4°C and bands 
were revealed after incubation with the recommended 
secondary antibody coupled to peroxidase using ECL. 
Scanned  images  were  quantified  using  scion  Image 
software and normalized to α-tubulin. 
 
Cell cycle. Samples of 5x10
5 of cells under test were 
fixed  with  95%  ethanol,  stained  with  50  µg/ml 
propidium iodide (PI), incubated over night at 4°C and 
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cytofluorimeter.  The  Kolmogorov-Smirnov  Statistic 
was used to represent the DNA content profile of MEF 
at the various passages. 
 
Statistical analysis. Data were analyzed using GraphPad 
Prism  (GraphPad  Sofware,  Inc.,  San  Diego,  CA). 
Comparisons were evaluated by unpaired t-test. A value 
of p<0.05 (*) was considered statistically significant. 
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